Cite
Abstract AP15: IDENTIFICATION OF P53 PRIONS AS AN INDEPENDENT PROGNOSTIC MARKER FOR SURVIVAL IN HIGH-GRADE SEROUS OVARIAN CANCER
MLA
Ignace Vergote, et al. “Abstract AP15: IDENTIFICATION OF P53 PRIONS AS AN INDEPENDENT PROGNOSTIC MARKER FOR SURVIVAL IN HIGH-GRADE SEROUS OVARIAN CANCER.” Clinical Cancer Research, vol. 25, Nov. 2019, p. AP15. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........054ca7b222677ae1447ccea13067a88c&authtype=sso&custid=ns315887.
APA
Ignace Vergote, Reinhard Horvat, Jalid Sehouli, Christine Wallisch, Katarzyna Koziel, B. Holzer, Eva Obermayr, Ioana Braicu, Georg Heinze, Sven Mahner, Els Van Nieuwenhuysen, Elisabeth Maritschnegg, Robert Zeillinger, Nicole Heinzl, Stuart Wilson, Nicole Concin, & Eva Schuster. (2019). Abstract AP15: IDENTIFICATION OF P53 PRIONS AS AN INDEPENDENT PROGNOSTIC MARKER FOR SURVIVAL IN HIGH-GRADE SEROUS OVARIAN CANCER. Clinical Cancer Research, 25, AP15.
Chicago
Ignace Vergote, Reinhard Horvat, Jalid Sehouli, Christine Wallisch, Katarzyna Koziel, B. Holzer, Eva Obermayr, et al. 2019. “Abstract AP15: IDENTIFICATION OF P53 PRIONS AS AN INDEPENDENT PROGNOSTIC MARKER FOR SURVIVAL IN HIGH-GRADE SEROUS OVARIAN CANCER.” Clinical Cancer Research 25 (November): AP15. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........054ca7b222677ae1447ccea13067a88c&authtype=sso&custid=ns315887.